Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Gluconate for Blood Loss Reduction in Cesarean Delivery
NCT06235749Recruiting
- Sponsor
- Rambam Health Care Campus
- Start
- Nov 2023
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of calcium gluconate in postpartum hemorrhage (PPH) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Change in mean hemoglobin drop at 24 hours. Started Nov 2023; status: recruiting.
02
Drugs
calcium gluconate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06235749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06235749.